• $94.99

Publisher Description

This book examines whether direct-to-consumer pharmaceutical advertising changed in response to recommendations made by the FDA in 2009 to enhance the informational and motivational value of advertising to be more accessible to minority populations and consequently work to reduce health disparities.

GENRE
Nonfiction
RELEASED
2018
August 31
LANGUAGE
EN
English
LENGTH
140
Pages
PUBLISHER
Lexington Books
SELLER
The Rowman & Littlefield Publishing Group
SIZE
5.7
MB